MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 20, 2006; DOI: 10.1124/mol.106.024836


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.024836v1
70/3/1071    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poeckel, D.
Right arrow Articles by Werz, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poeckel, D.
Right arrow Articles by Werz, O.


Received for publication March 22, 2006.
Revised June 9, 2006.
Accepted for publication June 20, 2006.

Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase

Daniel Poeckel 1, Lars Tausch 2, Nicole Kather 3, Johann Jauch 3, Oliver Werz 1*

1 Univ. Tuebingen 2 Univ. Frankfurt 3 Univ. of Saarland

* Address correspondence to: E-mail: oliver.werz{at}uni-tuebingen.de

Abstract

Boswellic acids inhibit the transformation of arachidonic acid to leukotrienes via 5-lipoxygenase but can also enhance the liberation of arachidonic acid in human leukocytes and platelets. Utilizing human platelets, we explored the molecular mechanisms underlying the boswellic acid-induced release of arachidonic acid and the subsequent metabolism by platelet-type 12-lipoxygenase (p12-LO). Both, {beta}-boswellic acid as well as 3-O-acetyl-11-keto-boswellic acid (AKBA) markedly enhanced the release of arachidonic acid via cytosolic phospholipase (PL)A2, whereas for generation of 12-hydro(pero)xyeicosatetraenoic acid (12-H(P)ETE), AKBA was less potent than {beta}-boswellic acid and was without effect at higher concentrations (≥ 30 µM). In contrast to thrombin, {beta}-boswellic acid-induced release of arachidonic acid and formation of 12-H(P)ETE was more rapid and occurred also in the absence of Ca2+. The Ca2+-independent release of arachidonic acid and 12-H(P)ETE production elicited by {beta}-boswellic acid was not affected by pharmacological inhibitors of signaling molecules relevant for agonist-induced arachidonic acid liberation and metabolism. Notably, in cell-free assays, {beta}-boswellic acid increased p12-LO catalysis about two-fold in the absence, but not in the presence of Ca2+, whereas AKBA inhibited p12-LO activity. No direct modulatory effects of boswellic acids on cPLA2 activity in cell-free assays were evident. Accordingly, immobilized KBA (linked to sepharose beads) selectively precipitated p12-LO from platelet lysates but failed to bind cPLA2. Taken together, we show that boswellic acids induce the release of arachidonic acid and the synthesis of 12-H(P)ETE in human platelets by unique, Ca2+-independent routes, and we identified p12-LO as a selective molecular target of boswellic acids.


Key words: Prostanoid, Phospholipase A2's, Calcium (G Protein Coupled Signals), MAP Kinase, HETEs, Leukotrienes, Lipoxygenases, Platelets





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics